Related Experiment Video

Updated: Jul 4, 2025

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

958

Japanese Study of the Effects of AMG (α1-Microglobulin) Reduction Rates on Survival (JAMREDS): A Protocol of a

Toshihide Naganuma1,2, Yoshiaki Takemoto1,2, Naohiro Kamada2,3

  • 1Department of Urology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Blood Purification
|February 4, 2024
PubMed
Abstract

Insights

The JAMREDS study investigates if higher removal rates of alpha1-microglobulin (AMG) in hemodialysis patients reduce mortality and cardiovascular disease (CVD) risk. This research aims to clarify the prognostic impact of large-middle molecule clearance.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Clinical Research

Background:

  • Dialysis therapy now removes middle molecules, including small-middle like β2-microglobulin.
  • Focus is shifting to large-middle molecules, such as α1-microglobulin (AMG), for improved clinical outcomes.
  • The prognostic significance of AMG reduction rates in hemodialysis patients remains undetermined.

Purpose of the Study:

  • To determine if AMG reduction rates associate with mortality and cardiovascular disease (CVD) events in hemodialysis patients.
  • To examine the impact of different dialysis modalities (HD, iHDF, online HDF) on survival and CVD events, considering AMG reduction.
  • To assess AMG reduction rates' effect on survival and CVD events within specific hemodialysis therapies.

Main Methods:

  • Prospective observational study (JAMREDS) involving 9,930 patients across 59 facilities.
  • Data collected via RED-Cap electronic data capture system.
  • Study observation period extends to the end of 2023, followed by data cleaning and analysis.

Main Results:

  • The study is ongoing, with data collection concluding at the end of 2023.
  • Analysis will focus on the relationship between AMG reduction rates and patient outcomes.
  • Comparisons with convection volumes will also be explored.

Conclusions:

  • This study is expected to offer novel insights into the link between large-middle molecule removal (e.g., AMG) and mortality/CVD risk.
  • Findings may inform future dialysis strategies to optimize patient prognosis.
Keywords:
HemodiafiltrationHemodialysisJAMREDSMiddle moleculesPrognosisα1-Microglobulin

More Related Videos

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

Published on: September 26, 2011

23.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
95
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141